Comments
Loading...
Interpace Biosciences Analyst Ratings and Price Targets | OTC:IDXG | Benzinga
Interpace Biosciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Interpace Biosciences Corp from these most-recent analyst ratings.
Analyst Ratings for Interpace Biosciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Interpace Biosciences (IDXG) stock?
There is no price target for Interpace Biosciences
What is the most recent analyst rating for Interpace Biosciences (IDXG)?
There is no analyst for Interpace Biosciences
When was the last upgrade for Interpace Biosciences (IDXG)?
There is no last upgrade for Interpace Biosciences
When was the last downgrade for Interpace Biosciences (IDXG)?
There is no last downgrade for Interpace Biosciences.
When is the next analyst rating going to be posted or updated for Interpace Biosciences (IDXG)?
There is no next analyst rating for Interpace Biosciences.
Is the Analyst Rating Interpace Biosciences (IDXG) correct?
There is no next analyst rating for Interpace Biosciences.
Browse analyst ratings and price targets on all stocks.
